Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.
Department of Surgery, University of Washington, Seattle, WA.
Crit Care Med. 2019 Jul;47(7):975-983. doi: 10.1097/CCM.0000000000003708.
To determine if higher fresh frozen plasma and platelet to packed RBC ratios are associated with lower 24-hour mortality in bleeding pediatric trauma patients.
Retrospective cohort study using the Pediatric Trauma Quality Improvement Program Database from 2014 to 2016.
Level I and II pediatric trauma centers participating in the Trauma Quality Improvement Program PATIENTS:: Injured children (≤ 14 yr old) who received massive transfusion (≥ 40 mL/kg total blood products in 24 hr). Of 123,836 patients, 590 underwent massive transfusion, of which 583 met inclusion criteria.
None.
Ratios of fresh frozen plasma:packed RBC and platelet:packed RBC. Of the 583 patients, 60% were male and the median age was 5 years (interquartile range, 2-10 yr). Overall mortality was 19.7% (95% CI, 16.6-23.2%) at 24 hours. There was 51% (adjusted relative risk, 0.49; 95% CI, 0.27-0.87; p = 0.02) and 40% (adjusted relative risk, 0.60; 95% CI, 0.39-0.92; p = 0.02) lower risk of death at 24 hours for the high (≥ 1:1) and medium (≥ 1:2 and < 1:1) fresh frozen plasma:packed RBC ratio groups, respectively, compared with the low ratio group (< 1:2). Platelet:packed RBC ratio was not associated with mortality (adjusted relative risk, 0.94; 95% CI, 0.51-1.71; p = 0.83).
Higher fresh frozen plasma ratios were associated with lower 24-hour mortality in massively transfused pediatric trauma patients. The platelet ratio was not associated with mortality. Although these findings represent the largest study evaluating blood product ratios in pediatric trauma patients, prospective studies are necessary to determine the optimum blood product ratios to minimize mortality in this population.
确定在出血性儿科创伤患者中,较高的新鲜冷冻血浆与血小板对红细胞比与较低的 24 小时死亡率相关。
使用 2014 年至 2016 年小儿创伤质量改进计划数据库进行回顾性队列研究。
参与创伤质量改进计划 PATIENTS 的一级和二级儿科创伤中心:接受大量输血(24 小时内接受≥40ml/kg 的总血液制品)的受伤儿童(≤14 岁)。在 123836 名患者中,有 590 名患者接受了大量输血,其中 583 名符合纳入标准。
无。
新鲜冷冻血浆:红细胞比和血小板:红细胞比。在 583 名患者中,60%为男性,中位年龄为 5 岁(四分位距,2-10 岁)。总体死亡率为 24 小时时为 19.7%(95%可信区间,16.6-23.2%)。高(≥1:1)和中(≥1:2 且<1:1)新鲜冷冻血浆:红细胞比组的 24 小时死亡风险分别降低 51%(调整后的相对风险,0.49;95%可信区间,0.27-0.87;p=0.02)和 40%(调整后的相对风险,0.60;95%可信区间,0.39-0.92;p=0.02),与低比值组(<1:2)相比。血小板:红细胞比与死亡率无关(调整后的相对风险,0.94;95%可信区间,0.51-1.71;p=0.83)。
在接受大量输血的儿科创伤患者中,较高的新鲜冷冻血浆比值与较低的 24 小时死亡率相关。血小板比值与死亡率无关。尽管这些发现代表了评估儿科创伤患者血液制品比值的最大研究,但仍需要前瞻性研究来确定最佳血液制品比值,以最大限度地降低该人群的死亡率。